Sanofi SA

Sanofi: Information concerning the total number of voting rights and shares - October 2024

20 11 2024 07:11:02 提供 Nasdaq GlobeNewswire

Press Release: Dupixent sBLA accepted for FDA review for the treatment of chronic spontaneous urticaria

15 11 2024 00:00:00 提供 Nasdaq GlobeNewswire

Press Release: Sarclisa recommended for EU approval by the CHMP to treat transplant-ineligible newly diagnosed multiple myeloma

14 11 2024 10:42:43 提供 Nasdaq GlobeNewswire

Press Release: Dupixent approved in the EU as the first and only medicine for young children with eosinophilic esophagitis

06 11 2024 00:00:00 提供 Nasdaq GlobeNewswire

Press Release: Sanofi Q3: 15.7% sales growth boosted by earlier-than-anticipated vaccine sales; 2024 business EPS guidance raised due to strong business performance

25 10 2024 00:30:00 提供 Nasdaq GlobeNewswire

Press Release: Dupixent late-breaking positive phase 3 data in chronic spontaneous urticaria to be presented at ACAAI

24 10 2024 07:00:00 提供 Nasdaq GlobeNewswire

Press Release: Sanofi and CD&R partner to fuel Opella’s ambitions in consumer healthcare

21 10 2024 00:30:00 提供 Nasdaq GlobeNewswire

Press Release: Sanofi and Orano join forces to develop next-generation radioligand medicines

17 10 2024 00:30:00 提供 Nasdaq GlobeNewswire

Press Release: Sanofi and Orano join forces to develop next-generation radioligand medicines

17 10 2024 00:30:00 提供 Nasdaq GlobeNewswire

Sanofi: Information concerning the total number of voting rights and shares - September 2024

15 10 2024 15:05:18 提供 Nasdaq GlobeNewswire

Press Release: Sanofi in discussions to sell a controlling stake in Opella

11 10 2024 01:30:00 提供 Nasdaq GlobeNewswire

Press Release: New Beyfortus data featured at IDWeek reinforce real-world effectiveness against RSV disease and hospitalization in infants

09 10 2024 00:00:00 提供 Nasdaq GlobeNewswire

Press Release: Dupixent approved in the US as the first-ever biologic medicine for patients with COPD

27 9 2024 08:35:00 提供 Nasdaq GlobeNewswire

Press Release: Dupixent approved in China as the first-ever biologic medicine for patients with COPD

27 9 2024 06:00:00 提供 Nasdaq GlobeNewswire

Press Release: Availability of the Q3 2024 Aide mémoire

26 9 2024 00:30:00 提供 Nasdaq GlobeNewswire

Press Release: Sarclisa approved in the US as the first anti-CD38 therapy in combination with standard-of-care treatment for adult patients with newly diagnosed multiple myeloma not eligible for transplant

20 9 2024 17:36:29 提供 Nasdaq GlobeNewswire

Press Release: Dupixent recommended for EU approval by the CHMP to treat eosinophilic esophagitis in children as young as 1 year old

20 9 2024 06:45:00 提供 Nasdaq GlobeNewswire

Press Release: Tolebrutinib demonstrated a 31% delay in time to onset of confirmed disability progression in non-relapsing secondary progressive multiple sclerosis phase 3 study

20 9 2024 04:30:00 提供 Nasdaq GlobeNewswire

Sanofi: Information concerning the total number of voting rights and shares - August 2024

16 9 2024 11:44:49 提供 Nasdaq GlobeNewswire

Press Release: Sanofi, RadioMedix, and Orano Med announce licensing agreement on next-generation radioligand medicine for rare cancers

12 9 2024 00:00:00 提供 Nasdaq GlobeNewswire